STOCK TITAN

AMETEK Announces Record Third Quarter Results and Raises Full Year Guidance

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

AMETEK (NYSE: AME) reported record third quarter 2025 results for the period ended September 30, 2025. Sales were a record $1.89 billion, up 11% year‑over‑year. GAAP EPS were $1.60; Adjusted EPS were a record $1.89, up 14%. GAAP operating income was $488.4 million (25.8% of sales); Adjusted operating income was $496.1 million, up 11%. EIG sales were $1.25 billion (+10%) and EMG sales were $646.3 million (+13%) with EMG operating income of $163.9 million (+25%).

AMETEK raised full‑year adjusted EPS guidance to $7.32–$7.37 (up 7%–8%) and expects Q4 sales ~+10% with adjusted EPS of $1.90–$1.95. The company will webcast its Q3 investor call on October 30, 2025.

Loading...
Loading translation...

Positive

  • Record sales of $1.89B in Q3 2025 (+11% YoY)
  • Record adjusted EPS of $1.89 in Q3 2025 (+14% YoY)
  • Raised 2025 adjusted EPS guidance to $7.32–$7.37 (+7%–8%)
  • Q4 sales expected ~+10% with adjusted EPS $1.90–$1.95
  • EMG operating income $163.9M (+25%) and margin +250 bps

Negative

  • Acquisition‑related pre‑tax costs of $19.7M in the quarter
  • Non‑cash after‑tax acquisition intangible amortization of $0.22 per share reduced GAAP EPS

News Market Reaction 8 Alerts

+7.67% News Effect
+$3.30B Valuation Impact
$46.26B Market Cap
0.4x Rel. Volume

On the day this news was published, AME gained 7.67%, reflecting a notable positive market reaction. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $3.30B to the company's valuation, bringing the market cap to $46.26B at that time.

Data tracked by StockTitan Argus on the day of publication.

BERWYN, Pa., Oct. 30, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced record financial results for the third quarter ended September 30, 2025.

AMETEK's third quarter 2025 sales were a record $1.89 billion, an 11% increase over the third quarter of 2024. On a GAAP basis, third quarter earnings per diluted share were $1.60. Adjusted earnings in the quarter were a record $1.89 per diluted share, up 14% from the third quarter of 2024. Adjusted earnings adds back non-cash, after-tax, acquisition-related intangible amortization of $0.22 per diluted share and excludes acquisition-related pre-tax costs of $19.7 million, or $0.07 per diluted share, for the FARO Technologies acquisition.

GAAP operating income was a record $488.4 million, or 25.8% of sales. Adjusted operating income was a record $496.1 million, up 11% versus last year's third quarter. A reconciliation of reported GAAP results to adjusted results is included in the financial tables accompanying this release and on the AMETEK website.

"AMETEK delivered impressive results in the third quarter, highlighted by double digit growth in sales, orders and earnings per share, along with an outstanding 90 basis points of margin expansion excluding the impact of recent acquisitions," stated David A. Zapico, AMETEK Chairman and Chief Executive Officer. "The strength of the AMETEK Growth Model and the excellent contributions from our colleagues led to record results in the quarter."

Electronic Instruments Group (EIG)
EIG sales in the third quarter were a record $1.25 billion, an increase of 10% over the same period in 2024. On a GAAP basis, EIG's third quarter operating income was $352.4 million, or 28.3% of sales. Adjusted EIG operating income was $360.2 million, up 6% from the prior year. 

"EIG delivered solid results in the quarter with strong profit growth and 50 basis points of margin expansion excluding the impact of recent acquisitions," stated Mr. Zapico. "Additionally, we are pleased with the progress of the Faro Technologies integration and excited for the growth opportunities ahead for our expanded metrology platform."

Electromechanical Group (EMG)
EMG sales in the third quarter were a record $646.3 million, up 13% from the third quarter of 2024. EMG's third quarter operating income increased 25% to a record $163.9 million, and operating income margins were 25.4% in the quarter, up 250 basis points versus the prior year's results.

"EMG's third quarter results were outstanding, with broad based sales and orders growth led by Paragon Medical, resulting in record operating income and sizeable margin expansion," noted Mr. Zapico. "This performance reflects the strength of our differentiated businesses and our unwavering focus on operational excellence."

2025 Outlook 
"Our businesses performed exceptionally well in the third quarter, delivering strong growth and impressive operating results," noted Mr. Zapico. "AMETEK's flexible operating structure, diverse and attractive end market exposures, and strong cash flows position us well for sustained success."

"For 2025, we continue to expect overall sales to be up mid-single digits compared to 2024. Adjusted earnings per diluted share are now expected to be in the range of $7.32 to $7.37, up 7% to 8% over the comparable basis for 2024. This is an increase from our previous guidance range of $7.06 to $7.20," he added.

"For the fourth quarter of 2025, overall sales are expected to be up approximately 10% compared to the same period last year. Adjusted earnings in the quarter are anticipated to be in the range of $1.90 to $1.95 per share, up 2% to 4% compared to the fourth quarter of 2024," concluded Mr. Zapico.

Conference Call
AMETEK will webcast its third quarter 2025 investor conference call on Thursday, October 30, 2025, beginning at 8:30 AM ET. The live audio webcast will be available and later archived in the Investors section of www.ametek.com.

About AMETEK
AMETEK (NYSE: AME) is a leading global provider of industrial technology solutions serving a diverse set of attractive niche markets with annualized sales of approximately $7.5 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, Technology Innovation, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. Founded in 1930, AMETEK has been listed on the NYSE for 95 years and is a component of the S&P 500. For more information, visit www.ametek.com.

Forward-looking Information
Statements in this news release relating to future events, such as AMETEK's expected business and financial performance, are "forward-looking statements." Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ materially from expectations. These factors and uncertainties include risks related to AMETEK's ability to consummate and successfully integrate future acquisitions; risks with international sales and operations, including supply chain disruptions, tariffs, trade disputes and currency conditions; AMETEK's ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve. A detailed discussion of these and other factors that may affect our future results is contained in AMETEK's filings with the U.S. Securities and Exchange Commission, including its most recent reports on Forms 10-K, 10-Q and 8-K. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.

Contact:
Kevin Coleman
Vice President, Investor Relations and Treasurer
kevin.coleman@ametek.com
Phone: 610.889.5247

AMETEK, Inc.

Consolidated Statement of Income

(In thousands, except per share amounts)

(Unaudited)






Three Months Ended
September 30,


Nine Months Ended
September 30,


2025


2024


2025


2024

Net sales

$      1,892,641


$      1,708,564


$      5,402,668


$      5,179,578









Cost of sales

1,206,505


1,092,754


3,455,643


3,347,860

Selling, general and administrative

197,756


169,959


542,190


521,137

     Total operating expenses

1,404,261


1,262,713


3,997,833


3,868,997

Operating income

488,380


445,851


1,404,835


1,310,581

Interest expense

(22,514)


(25,118)


(58,364)


(90,962)

Other (expense) income, net

(17,901)


(1,888)


(22,115)


(2,435)

Income before income taxes

447,965


418,845


1,324,356


1,217,184

Provision for income taxes

76,549


78,604


242,815


228,317

Net income

$         371,416


$         340,241


$      1,081,541


$         988,867









Diluted earnings per share

$               1.60


$               1.47


$               4.67


$               4.26

Basic earnings per share

$               1.61


$               1.47


$               4.69


$               4.28









Weighted average common shares outstanding:








     Diluted shares

231,670


232,224


231,561


232,188

     Basic shares

230,733


231,342


230,740


231,292









Dividends per share

$               0.31


$               0.28


$               0.93


$               0.84

 

AMETEK, Inc.

Information by Business Segment

(In thousands)

(Unaudited)






Three Months Ended

September 30,


Nine Months Ended

September 30,


2025


2024


2025


2024

Net sales:








Electronic Instruments

$      1,246,332


$      1,134,588


$      3,549,576


$      3,444,980

Electromechanical

646,309


573,976


1,853,092


1,734,598

Consolidated net sales

$      1,892,641


$      1,708,564


$      5,402,668


$      5,179,578









Operating income:








Segment operating income:








Electronic Instruments

$         352,437


$         338,963


$      1,050,915


$      1,041,760

Electromechanical

163,875


131,519


436,481


345,312

Total segment operating income

516,312


470,482


1,487,396


1,387,072

Corporate administrative expenses

(27,932)


(24,631)


(82,561)


(76,491)

Consolidated operating income

$         488,380


$         445,851


$      1,404,835


$      1,310,581

 

AMETEK, Inc.

Condensed Consolidated Balance Sheet

(In thousands)






September 30,


December 31,


2025


2024


(Unaudited)



ASSETS




Current assets:




     Cash and cash equivalents

$         439,237


$         373,999

     Receivables, net

1,135,967


948,830

     Inventories, net

1,153,074


1,021,713

     Other current assets

333,267


258,490

          Total current assets

3,061,545


2,603,032





Property, plant and equipment, net

845,603


818,611

Right of use assets, net

267,589


235,666

Goodwill

7,185,294


6,555,877

Other intangibles, investments and other assets

4,822,226


4,417,983

          Total assets

$    16,182,257


$    14,631,169





LIABILITIES AND STOCKHOLDERS' EQUITY




Current liabilities:




     Short-term borrowings and current portion of long-term debt, net

$      1,038,143


$         654,346

     Accounts payable and accruals

1,611,660


1,444,241

          Total current liabilities

2,649,803


2,098,587





Long-term debt, net

1,426,072


1,425,375

Deferred income taxes and other long-term liabilities

1,579,506


1,451,903

Stockholders' equity

10,526,876


9,655,304

          Total liabilities and stockholders' equity

$    16,182,257


$    14,631,169

 

AMETEK, Inc.

Reconciliations of GAAP to Non-GAAP Financial Measures

(In thousands, except per share amounts)

(Unaudited)






Three Months Ended September 30,




2025


2024



EIG Segment operating income (GAAP)

$    352,437


$   338,963



Acquisition-related costs(1)

7,750




Adjusted EIG Segment operating income (Non-GAAP)

$    360,187


$   338,963









Operating income (GAAP)

$    488,380


$   445,851



Acquisition-related costs(1)

7,750




Adjusted Operating income (Non-GAAP)

$    496,130


$   445,851









Other Income (Expense), net

$     (17,901)


$      (1,888)



Acquisition-related costs(1)

11,992




Adjusted Other Income (Expense), net

$      (5,909)


$      (1,888)









Diluted earnings per share (GAAP)

$          1.60


$         1.47



Acquisition-related costs(1)

0.09




Income tax benefit on acquisition-related costs(1)

(0.02)




Pretax amortization of acquisition-related intangible assets

0.29


0.26



Income tax benefit on amortization of acquisition-related intangible assets

(0.07)


(0.06)



Rounding


(0.01)



Adjusted Diluted earnings per share (Non-GAAP)

$          1.89


$         1.66














Change

EIG Segment operating margin (GAAP)

28.3 %


29.9 %



Acquisition-related costs(1)

0.6 %


— %



Dilutive impact of acquisitions(2)

1.5 %


— %



Adjusted EIG Segment operating margin (Non-GAAP)

30.4 %


29.9 %


0.5 %







Operating income margin (GAAP)

25.8 %


26.1 %



Acquisition-related costs(1)

0.4 %


— %



Dilutive impact of acquisitions(2)

0.8 %


— %



Adjusted Operating income margin (Non-GAAP)

27.0 %


26.1 %


0.9 %



(1) -

Acquisition-related costs are comprised of integration costs recorded in Cost of Sales and transaction costs unique to completed business combinations recorded in Other Income (Expense), net.

(2) -

Excludes the dilutive impact from acquisitions completed in the last twelve months.

 

AMETEK, Inc.

Reconciliations of GAAP to Non-GAAP Financial Measures

(Unaudited)




Forecasted Diluted Earnings Per Share


Three Months Ended


Year Ended


December 31, 2025


December 31, 2025


Low


High


Low


High









Diluted earnings per share (GAAP)

$             1.68


$             1.73


$          6.34


$          6.39

Pretax amortization of acquisition-related intangible assets

0.29


0.29


1.20


1.20

Income tax benefit on amortization of acquisition-related intangible assets

(0.07)


(0.07)


(0.29)


(0.29)

Acquisition-related costs(1)



0.09


0.09

Income tax benefit on acquisition-related costs(1)



(0.02)


(0.02)

Adjusted Diluted earnings per share (Non-GAAP)

$             1.90


$             1.95


$          7.32


$          7.37



(1) -

Acquisition-related costs are comprised of integration costs recorded in Cost of Sales and transaction costs unique to completed business combinations recorded in Other Income (Expense), net.

 

Use of Non-GAAP Financial Information

The Company supplements its consolidated financial statements presented on a U.S. generally accepted accounting principles ("GAAP") basis with certain non-GAAP financial information to provide investors with greater insight, increased transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making. Reconciliation of non-GAAP measures to their most directly comparable GAAP measures are included in the accompanying financial tables. These non-GAAP financial measures should be considered in addition to, and not as a replacement for, or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.

The non-GAAP financial measures referenced in this press release include adjusted operating income, adjusted operating margin, and adjusted earnings per share. These measures are adjusted to exclude items that management does not consider indicative of AMETEK's ongoing operational performance, such as after-tax acquisition-related intangible amortization and acquisition-related costs (including transaction costs, purchase accounting adjustments, and integration costs).

In providing forward-looking guidance for quarterly and full-year GAAP and non-GAAP measures, the Company has not included adjustments, such as acquisition-related costs, whose timing and/or magnitude are contingent on future events.

The Company believes that these measures provide useful information to investors by reflecting additional ways of viewing AMETEK's operations that, when reconciled to the comparable GAAP measure, helps our investors to better understand the long-term profitability trends of our business, and facilitates easier comparisons of our profitability to prior and future periods and to our peers.

Cision View original content:https://www.prnewswire.com/news-releases/ametek-announces-record-third-quarter-results-and-raises-full-year-guidance-302598952.html

SOURCE AMETEK, Inc.

FAQ

What were AMETEK's Q3 2025 sales and how did they compare to Q3 2024 (AME)?

AMETEK reported Q3 2025 sales of $1.89 billion, an 11% increase versus Q3 2024.

What was AMETEK's Q3 2025 adjusted EPS and GAAP EPS (AME)?

Q3 2025 adjusted EPS were $1.89 (record) and GAAP EPS were $1.60.

How did AMETEK change its full‑year 2025 guidance for adjusted EPS (AME)?

AMETEK raised full‑year 2025 adjusted EPS guidance to $7.32–$7.37, up 7%–8% versus 2024 on a comparable basis.

What does AMETEK expect for Q4 2025 sales and adjusted EPS (AME)?

AMETEK expects Q4 2025 overall sales to be up about 10% year‑over‑year and adjusted EPS of $1.90–$1.95.

How much did acquisitions affect AMETEK's Q3 2025 results (AME)?

The quarter included acquisition‑related pre‑tax costs of $19.7M and after‑tax intangible amortization of $0.22 per share.
Ametek

NYSE:AME

AME Rankings

AME Latest News

AME Latest SEC Filings

AME Stock Data

46.44B
229.30M
0.36%
90.08%
1.13%
Specialty Industrial Machinery
Industrial Instruments for Measurement, Display, and Control
Link
United States
BERWYN